J. Amerena 1, P. Steg 2, D. Bhatt 3, G. Watts 4, R. Giugliano 5, M. Miller 6, E. Brinton 7, T. Jacobson 8, S. Ketchum 9, G. Giugliano 10, R. Mason 11, J. Tardif 12, F. Martens 13, C. Ballantyne 14, M. Budoff 15, C. Gibson 16
1 University Hospital Geelong, Geelong, Vic, Australia
2 Université de Paris, FACT (French Alliance for Cardiovascular Trials), Assistance Publique–Hôpitaux de Paris, Hôpital Bichat, Paris, France
3 Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY, USA
4 School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia
5 Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
6 Department of Medicine, Crescenz Veterans Affairs Medical Center and University of Pennsylvania School of Medicine, Philadelphia, PA, USA
7 Utah Lipid Center, Salt Lake City, UT, USA
8 Lipid Clinic and Cardiovascular Risk Reduction Program, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
9 Amarin Pharma, Inc., Bridgewater, NJ, USA
10 Children’s National Hospital, Washington DC, USA
11 Brigham and Women’s Hospital, Harvard Medical School, and Elucida Research, Boston, MA, USA
12 Montreal Heart Institute, Université de Montréal, Montreal, Canada
13 Dutch Network for Cardiovascular Research and the Department of Cardiology, Deventer Hospital, Deventer, The Netherlands
14 Department of Medicine, Baylor College of Medicine, and the Texas Heart Institute, Houston, TX, USA
15 David Geffen School of Medicine, Lundquist Institute, Torrance, CA, USA
16 Harvard Medical School, Baim Institute for Clinical Research, Boston, MA, USA